User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and Tanzania
Open Access
- 11 May 2026
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 11 (5) , e019902
Abstract
Background: Timely and appropriate diagnosis and treatment are key to ending tuberculosis (TB). Incorporating users’ preferences when implementing decentralised strategies for diagnosis may facilitate scale-up and impact. This qualitative study embedded within a cluster randomised controlled trial explored the values and preferences of multiple stakeholders regarding a TB diagnostic strategy using the Truenat platform, mycobacterium tuberculosis (MTB) Plus and rifampicin Dx Assays in Mozambique and Tanzania. Methods: We conducted semi-structured interviews with people with presumptive TB (n=35), professional users (laboratory technicians, nurses, clinicians, n=19) and national decision-makers (n=5). Direct observations of testing procedures and usability surveys (n=12) were also conducted. Thematic analysis was performed, informed by the Consolidated Framework for Implementation Research. Results: Facilities varied in testing capacity, number of cases and time-to-results (from same-day to >2 weeks). Availability and supply of reagents and cartridges were described as an issue by healthcare providers and a potential cause for delayed results. The Truenat platform for detection of TB was considered easy to use (median SUS score 90/100) as well as acceptable and fit to the context where the evaluation was conducted. Truenat’s advantage was appreciated in facilities with limited prior testing capacity (eg, shipping samples, using microscopy), including short time-to-results, reduced need to return to provide more samples and fewer infrastructure needs (compared with GeneXpert). People with presumptive TB preferred the same-day results and rapid initiation of treatment enabled by Truenat testing. Some viewed waiting longer time (>1 day) for the results acceptable if it were to result in increased accuracy. Regarding the diagnostic process, participants valued the support and counselling from the healthcare workers. Conclusions: The Truenat platform and TB assays were perceived as easy to use by health providers, and as acceptable and feasible across stakeholder groups. Its implementation in decentralised settings was considered a preferred alternative to off-site Xpert testing for TB in Mozambique and Tanzania. Trial registration number: NCT04568954 .Keywords
Funding Information
- European and Developing Countries Clinical Trials Partnership (RIA2017S-2007)
This publication has 33 references indexed in Scilit:
- Diagnostic accuracy of swab-based molecular tests for tuberculosis using near-point-of-care platforms: a multi-country evaluationEBioMedicine, 2025
- Implementing the Molbio Truenat platform and tuberculosis assays versus standard of care at primary care clinics for the detection and treatment of tuberculosis in Mozambique and Tanzania (TB-CAPT CORE): a cluster-randomised trialThe Lancet Primary Care, 2025
- Preferences for tuberculosis diagnostic test features among people tested for tuberculosis: a multicountry discrete choice experimentThe Lancet Primary Care, 2025
- Comparing the accuracy of computer-aided detection (CAD) software and radiologists from multiple countries for tuberculosis detection in chest X-RaysScientific Reports, 2025
- Performance of stool-based molecular tests and processing methods for paediatric tuberculosis diagnosis: a systematic review and meta-analysisThe Lancet Microbe, 2024
- Computer-aided detection of tuberculosis from chest radiographs in a tuberculosis prevalence survey in South Africa: external validation and modelled impacts of commercially available artificial intelligence softwareThe Lancet Digital Health, 2024
- Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant dataThe Lancet Global Health, 2023
- The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysiseClinicalMedicine, 2020
- Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research AgendaAdministration and Policy in Mental Health and Mental Health Services Research, 2010
- An Empirical Evaluation of the System Usability ScaleInternational Journal of Human–Computer Interaction, 2008